{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:48:29Z","timestamp":1794606509434,"version":"4.9.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Sarcopenia, malnutrition, physical deconditioning, and frailty contribute to a significantly altered quality of life (QoL) in patients with cirrhosis and sarcopenia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate the sarcopenia-linked alterations of QoL by SarQoL\u00ae questionnaire in patients with end-stage liver disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Consecutive patients with liver cirrhosis, admitted to our department between May and August 2021, completed the SarQoL\u00ae questionnaire by themselves. They were evaluated for sarcopenia according to the 2019 European Working Group on Sarcopenia in Older People (EWGSOP) definition [hand grip cut-offs and skeletal muscle index (SMI) calculation at CT scan].<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 71 patients with liver cirrhosis were included in the study, with a median age of 54 years. Sarcopenia was present in 31.2% of patients with Child-Pugh class A, in 58.3% with class B, and in 93.5% with class C. The SarQoL\u00ae score was statistically significant and lower in Child-Pugh class C vs. class B and class A (70.2 vs. 66.5 vs. 52.5 points, <jats:italic>p<\/jats:italic> = 0.0002). The SarQoL\u00ae score was evaluated according to different complications of cirrhosis, with statistically significant lower scores in patients with sarcopenia (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001), in patients with ascites requiring paracentesis (<jats:italic>p<\/jats:italic> = 0.0006), and in patients with hepatic encephalopathy (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001). A cut-off level of 75.9 points for SarQoL\u00ae score can accurately detect sarcopenia in patients with end-stage liver disease [area under the receiver operating characteristic (AUROC) curve of.823, SE of 92.1%, SP of 45.5%, positive predictive value (PPV) and negative predictive value (NPV) of 66 and 83.3%, respectively, correctly classified 73.2% of cirrhotic patients with sarcopenia].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The use of SarQoL\u00ae questionnaire in cirrhotic patients can, at the same time, evaluate the quality of life and identify subjects with sarcopenia and altered QoL.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2022.774044","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:00:50Z","timestamp":1645783250000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Assessment of Sarcopenia Related Quality of Life Using SarQoL\u00ae Questionnaire in Patients With Liver Cirrhosis"],"prefix":"10.3389","volume":"9","author":[{"given":"Speranta","family":"Iacob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Mina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matei","family":"Mandea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razvan","family":"Iacob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Vadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Voichita","family":"Boar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgeta","family":"Ionescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Buzescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Gheorghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Gheorghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.7861\/clinmed.2020-0089","article-title":"Sarcopenia in cirrhosis: a practical overview","volume":"20","author":"Dhaliwal","year":"2020","journal-title":"Clin Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the american association for the study of liver diseases","volume":"74","author":"Lai","year":"2021","journal-title":"Hepatology."},{"key":"B3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/nu12020547","article-title":"Sarcopenia and liver cirrhosis - comparison of the European working group on sarcopenia criteria 2010 and 2019","volume":"12","author":"Traub","year":"2020","journal-title":"Nutrients."},{"key":"B4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1038\/ctg.2015.31","article-title":"Inclusion of sarcopenia within MELD (MELD Sarcopenia) and the prediction of mortality in patients with cirrhosis","volume":"6","author":"Montano-Loza","year":"2015","journal-title":"Clin Transl Gastroenterol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jceh.2019.12.003","article-title":"Sarcopenia in cirrhosis: fallout on liver transplantation","volume":"10","author":"Kumar","year":"2020","journal-title":"J Clin Exp Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1111\/ajt.15392","article-title":"Frailty in liver transplantation: an expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice","volume":"19","author":"Lai","year":"2019","journal-title":"Am J Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/apt.15571","article-title":"Review article: malnutrition\/sarcopenia and frailty in patients with cirrhosis","volume":"51","author":"Bunchorntavakul","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/0269216318807051","article-title":"Symptom prevalence and quality of life of patients with end-stage liver disease: a systematic review and meta-analysis","volume":"33","author":"Peng","year":"2019","journal-title":"Palliat Med."},{"key":"B10","unstructured":"Deaths from liver disease: implications for end of life care in England\n            EffiongK\n            OsinowoA\n            PringA\n          2012"},{"key":"B11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1111\/liv.12569","article-title":"The burden of alcoholism in fifteen years of cirrhosis hospital admissions in Portugal","volume":"35","author":"Marinho","year":"2015","journal-title":"Liver Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-3-319-57379-3_19","article-title":"Sarcopenia and its impact on quality of life","volume":"987","author":"Tsekoura","year":"2017","journal-title":"Adv Exp Med Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ageing\/afv133","article-title":"Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL","volume":"44","author":"Beaudart","year":"2015","journal-title":"Age Ageing."},{"key":"B14","unstructured":""},{"key":"B15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/jcsm.12149","article-title":"Validation of the SarQoL, a specific health-related quality of life questionnaire for sarcopenia","volume":"8","author":"Beaudart","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14737167.2017.1360768","article-title":"Current review of the SarQoL\u00ae: a health-related quality of life questionnaire specific to sarcopenia","volume":"17","author":"Beaudart","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/jcsm.12333","article-title":"Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score","volume":"9","author":"Kang","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7637","DOI":"10.3748\/wjg.v21.i25.7637","article-title":"Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score","volume":"21","author":"Kim","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ajg.2017.443","article-title":"The liver frailty index improves mortality prediction of the subjective clinician assessment in patients with cirrhosis","volume":"113","author":"Lai","year":"2018","journal-title":"Am J Gastroenterol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11657-018-0516-7","article-title":"Psychometric performance of the Romanian version of the SarQoL\u00ae, a health-related quality of life questionnaire for sarcopenia","volume":"12","author":"Gasparik","year":"2017","journal-title":"Arch Osteoporos."},{"key":"B21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/jcsm.12687","article-title":"Evaluating quality of life in frailty: applicability and clinimetric properties of the SarQoL\u00ae questionnaire","volume":"12","author":"Geerinck","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.774044\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T10:00:54Z","timestamp":1645783254000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.774044\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":21,"alternative-id":["10.3389\/fnut.2022.774044"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.774044","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"774044"}}